Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Charles River Laboratories International, Inc. (CRL) Investigation
News provided byACCESSWIRE
Sep 19, 2023, 12:45 PM ET
NEW YORK, NY / ACCESSWIRE / September 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE:CRL). Investors who purchased Charles River securities prior to May 5, 2020, and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/crl.
The investigation concerns whether Charles River and certain of its officers and/or directors have allegedly engaged in corporate wrongdoing.
If you are aware of any facts relating to this investigation or purchased Charles River shares, you can assist with this investigation by visiting the firm's site: www.bgandg.com/crl. You can also contact Peretz Bronstein or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized law firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | email@example.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com:
NOTE: This content is not written by or endorsed by "KRQE", its advertisers, or Nexstar Media Inc.